John Rhodes to Septal Occluder Device
This is a "connection" page, showing publications John Rhodes has written about Septal Occluder Device.
Connection Strength
1.019
-
Combined prospective United States clinical study data for the GORE(?) HELEX(?) septal occluder device. Catheter Cardiovasc Interv. 2014 May 01; 83(6):944-52.
Score: 0.458
-
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke. N Engl J Med. 2017 09 14; 377(11):1033-1042.
Score: 0.147
-
Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study. Int J Stroke. 2017 12; 12(9):998-1004.
Score: 0.142
-
Device closure of secundum atrial septal defects in infants weighing less than 8 kg. Pediatr Cardiol. 2014 Oct; 35(7):1124-31.
Score: 0.116
-
A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk. Catheter Cardiovasc Interv. 2013 Mar; 81(4):654-9.
Score: 0.105
-
Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study. Catheter Cardiovasc Interv. 2022 04; 99(5):1551-1557.
Score: 0.049